Prot# AVF2562s: Phase II Trial of Bevacizumab in Combination with FOLFIRI Chemotherapy as First-Line Therapy of Colorectal Cancer: The BAFIL (Bevacizumab and 5-FU, Irinotecan, Leucovorin) Trial (NU Prot# NU V04I8)

Project: Research project

Project Details

StatusFinished
Effective start/end date9/23/05 → 9/30/09

Funding

  • Genentech, Inc. (AVF2562s)